JSJIX
Price
$14.10
Change
+$0.18 (+1.29%)
Updated
Apr 11 closing price
Net Assets
206.46M
VEXRX
Price
$91.03
Change
+$1.37 (+1.53%)
Updated
Apr 11 closing price
Net Assets
19.79B
Ad is loading...

JSJIX vs VEXRX

Header iconJSJIX vs VEXRX Comparison
Open Charts JSJIX vs VEXRXBanner chart's image
JHancock Small Cap Dynamic Growth I
Price$14.10
Change+$0.18 (+1.29%)
VolumeN/A
Net Assets206.46M
Vanguard Explorer Adm
Price$91.03
Change+$1.37 (+1.53%)
VolumeN/A
Net Assets19.79B
JSJIX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSJIX vs. VEXRX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSJIX is a Buy and VEXRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. JSJIX (206M). JSJIX pays higher dividends than VEXRX: JSJIX (3.75) vs VEXRX (0.56). JSJIX was incepted earlier than VEXRX: JSJIX (7 years) vs VEXRX (23 years). JSJIX (1.07) is less costly to investors than VEXRX (0.34). JSJIX is a more actively managed with annual turnover of: 177.00 vs. VEXRX (35.00). VEXRX has a lower initial minimum investment than JSJIX: VEXRX (50000) vs JSJIX (250000). JSJIX annual gain was more profitable for investors over the last year : -8.31 vs. VEXRX (-16.43). VEXRX return over 5 years is better than : 16.37 vs. JSJIX (-3.44).
JSJIXVEXRXJSJIX / VEXRX
Total Expense Ratio1.060.34312%
Annual Report Gross Expense Ratio1.070.34315%
Fund Existence7 years23 years-
Gain YTD-16.447-16.088102%
Front LoadN/AN/A-
Min. Initial Investment25000050000500%
Min. Initial Investment IRAN/AN/A-
Net Assets206M19.8B1%
Annual Yield % from dividends3.750.56666%
Returns for 1 year-8.31-16.4351%
Returns for 3 years-9.52-13.2172%
Returns for 5 years-3.4416.37-21%
Returns for 10 yearsN/A-2.96-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI4.290.30
+7.52%
Karyopharm Therapeutics Inc.
COOP110.001.44
+1.33%
Mr Cooper Group
HWM125.671.48
+1.19%
Howmet Aerospace
CASH67.790.59
+0.88%
Pathward Financial
PFIS40.810.14
+0.34%
Peoples Financial Services Corp